PEPFAR and AstraZeneca launch partnership across HIV and hypertension services in Africa
|
13 September 2016 |
Benralizumab phase III trials show positive results in severe asthma
|
05 September 2016 |
AstraZeneca and Lilly receive FDA Fast Track designation for AZD3293, an investigational treatment for early Alzheimer's disease
|
22 August 2016 |
AstraZeneca enters licensing agreements with LEO Pharma in skin diseases
|
01 July 2016 |
New antibiotic Zavicefta approved in the European Union for patients with serious bacterial infections
|
28 June 2016 |
AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines portfolio
|
09 June 2016 |
AstraZeneca licenses Zurampic to Grünenthal GmbH in Europe and Latin America
|
02 June 2016 |
AstraZeneca highlights continued progress of oncology pipeline at ASCO 2016
|
20 May 2016 |
Selumetinib granted Orphan Drug Designation in the US for adjuvant treatment of differentiated thyroid cancer
|
12 May 2016 |
AstraZeneca completes acquisition of Takeda's respiratory business
|
09 May 2016 |